Back
Biomarin Pharmaceutical 10K Form
Buy
57
BMRN
Biomarin Pharmaceutical
Last Price:
62.58
Seasonality Move:
12.47%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-26 | 10Q | BMRN/Biomarin Pharmaceutical Quarterly |
| 2024-02-26 | 10K | BMRN/Biomarin Pharmaceutical Annual |
| 2023-11-02 | 10Q | BMRN/Biomarin Pharmaceutical Quarterly |
| 2023-08-02 | 10Q | BMRN/Biomarin Pharmaceutical Quarterly |
| 2023-04-28 | 10Q | BMRN/Biomarin Pharmaceutical Quarterly |
| 2023-02-27 | 10K | BMRN/Biomarin Pharmaceutical Annual |
Receive BMRN News And Ratings
See the #1 stock for the next 7 days that we like better than BMRN
BMRN Financial Statistics
Sales & Book Value
| Annual Sales: | $2.42B |
|---|---|
| Cash Flow: | $200.31M |
| Price / Cash Flow: | 40.41 |
| Annual Sales: | $28.41 |
| Price / Book: | 2.18 |
Profitability
| EPS (TTM): | 1.67000 |
|---|---|
| Net Income (TTM): | $322.29M |
| Gross Margin: | $1.9B |
| Return on Equity: | 6.29% |
| Return on Assets: | 4.69% |
Biomarin Pharmaceutical Earnings Forecast
Key Biomarin Pharmaceutical Financial Ratios
- The Gross Profit Margin over the past 26 years for BMRN is 78.72%.
- The Selling, General & Administrative Expenses for BMRN have been equal to 38.74% of Gross Profit Margin.
- The Research & Development expenses have been 30.87% of Revenue.
- The Interest Expense is 9.99% of Operating Income.
- The Net Earning history of BMRN is 6.93% of Total Revenues.
- Per Share Earnings over the last 26 years have been positive in 14 years.
Biomarin Pharmaceutical Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BMRN |
| CUSIP: | 09061G |
| Website: | biomarin.com |
Debt
| Debt-to-Equity Ratio: | 0.11 |
|---|---|
| Current Ratio: | 4.27 |
| Quick Ratio: | 2.39 |
Price-to-Earnings
| Trailing P/E Ratio: | 71.18 |
|---|---|
| Forward P/E Ratio: | 15.1 |
BMRN Technical Analysis vs Fundamental Analysis
Buy
57
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy or a Sell?
-
Biomarin Pharmaceutical stock is rated a Buy
The current Biomarin Pharmaceutical [BMRN] share price is $62.56. The Score for BMRN is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.